Clinical Trial Update: Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of QL0605 injections given at different timepoints for chemotherapy-induced febrile neutropenia; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Febrile Neutropenia

Drugs mentioned

• QL0605 injections

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Chemotherapy-Induced Febrile Neutropenia | Phase 4 | Status: RECRUITING